Navigation Links
Regado Biosciences Reports Clinical Results for REG1 Anticoagulation System at European Society of Cardiology Congress 2008
Date:9/2/2008

s were minor bleeds at the venous access

site. The incidence of additional minor events, including headache,

dizziness, nausea, fatigue and hypotension, was similar to placebo.

"Our studies consistently have confirmed the two major attributes of the REG1 system, rapid anticoagulant activity and rapid and predictable reversal of this effect," stated David J. Mazzo, Ph.D., President and Chief Executive Officer of Regado Biosciences. "Based on the encouraging Phase I study data, we anticipate results from our ongoing Phase IIa studies evaluating REG1 in

patients undergoing elective PCI will further confirm that REG1 has the potential to replace standard heparin therapy."

"In striving to meet the needs of individual patients in varied and oftentimes complex settings, it is essential for physicians to quickly, safely and effectively achieve the desired anticoagulation effect and, when required for specific clinical indications, to attenuate or fully reverse this effect," stated Richard C. Becker, M.D., Professor of Medicine, Duke University Medical Center, and Director, Duke Cardiovascular Thrombosis Center, Duke Clinical Research Institute. "As we enter a new era of anticoagulant pharmacotherapy, a therapeutic system offering these attributes would be of great benefit and may have a profound impact on patient care."

Clinician-scientists from the Duke Clinical Research Institute (DCRI) and Regado evaluated REG1 in three Phase I studies: Phase Ia, a healthy volunteer drug dose-escalating pharmacokinetic-pharmacodynamic (PK-PD) study; Phase Ib, a drug dose-escalating study in subjects with stable coronary artery disease who were receiving aspirin with or without clopidogrel; and Phase Ic, a multiple exposure, dose-ranging study in 39 healthy volunteers. Top-line results from these three studies were presented last year at the American Heart Association's 2007 Scientific Sessions and subsequently published in top-tier scientifi
'/>"/>

SOURCE Regado Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System
2. Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions
3. Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions
4. Regado Biosciences Announces Publication in Circulation of Clinical Trial Results of REG1 Anticoagulation System
5. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
6. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
7. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
8. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
9. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
10. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
11. Alacrity Biosciences Announces Positive Results from a Phase 2 Study of Its Dry Eye Treatment ALTY-0501
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... DES MOINES, Iowa , Jan. 23, 2015  The Partnership to ... Iowa health care leaders and a new study ... prescription medications. The PFCD is a nationwide coalition working to educate ... The research released at the Capitol was focused on how the ...
(Date:1/23/2015)... Fla. and DUBLIN , Jan. ... the agreement with KRS Global Biotechnology, Inc. for the compounding, ... be compounded for shipment in the United States ... FDA approved Outsourcing Facility capable of compounding naltrexone tablets in ...
(Date:1/23/2015)... Fla. , Jan. 23, 2015  iMD Companies, Inc. (ICBU) ... to increase market share and grab a foothold in the ... influence, production capabilities and a presence in the sector, and ... facilitate the growth of hemp and medical marijuana, iMD is ...
Breaking Medicine Technology:New research shows Iowa health exchange would benefit from improvements 2New research shows Iowa health exchange would benefit from improvements 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2
... Wash., Sept. 29, 2011 Cardiac Dimensions®, Inc. today ... approval for a newly enhanced version of its CARILLON® ... failure patients suffering from functional mitral regurgitation (FMR). Receipt ... a commercial launch of the enhanced device in Europe, ...
... BELLEVUE, Wash., Sept. 29, 2011 The Educational Review ... on Sept. 28 at the Meyedenbauer Center in Bellevue, ... to national pharmacy thought leaders discuss the challenges of ... Mark Neuenschwander, the 2010 recipient of the Institute for ...
Cached Medicine Technology:Cardiac Dimensions® Receives CE Mark Approval for Enhanced CARILLON® Mitral Contour System™ 2Cardiac Dimensions® Receives CE Mark Approval for Enhanced CARILLON® Mitral Contour System™ 3
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post ... insurance policy . , Auto insurance quotes help many ... no longer necessary to call an agent or visit an ... on a single website: http://autocarinsurancebest.com/ . , Every business ...
(Date:1/22/2015)... Joan Lunden, award-winning American journalist, beloved ... upcoming 32nd Annual Miami Breast Cancer Conference ... LLC (PER®) , shares that “a fast-growing, virulent” cancer ... she had not followed up her clean mammogram with ...
(Date:1/22/2015)... (PRWEB) January 23, 2015 Recently, Weddingshe.com has ... catalog, and has announced its highest annual revenues in the ... on its popular glamorous wedding dresses. , According to the ... important wedding dress promotions for them in 2015. This point ...
(Date:1/22/2015)... 2015 Payday lending practices in four ... cause financial distress to the states that permit them, ... University’s Center on Race and Wealth. , While they ... payday loans at the same time substantially depress economic ...
(Date:1/22/2015)... a famous dress online store for wedding dresses and other ... of wedding dresses , and launches a site-wide women’s dress ... on your big day; the wedding gown is the most ... find the most suitable wedding dress. Now, we are proud ...
Breaking Medicine News(10 mins):Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2
... ... ... , ... , , , ...
... ... ... , ... , , , , ...
... ... ... , ... , , ...
... , A new study suggests a trend toward ... autistic preschoolers and supports the notion that mothers ... stress than mothers with typically developing children. ... statistically significant, the trend may indicate the presence ...
... ... On Friday 5th March 2010, LazyTown superhero Sportacus (aka Magnus Scheving) ... Hispanic Health youth soccer clinic, in Washington, D.C. In addition to ... on a 25 date tour to Hispanic communities throughout the US, helping ...
... ... ... ... ...
Cached Medicine News:Health News:Highmark and its Employees Donate $161,686 for Haiti Disaster Relief Efforts 2Health News:Highmark and its Employees Donate $161,686 for Haiti Disaster Relief Efforts 3Health News:Navvis & Company Acquires Physician Executive Management Center 2Health News:Navvis & Company Acquires Physician Executive Management Center 3Health News:Navvis & Company Acquires Physician Executive Management Center 4Health News:Department of Public Welfare Recognizes Contributions of Pennsylvanians with Developmental Disabilities 2Health News:A possible early glimpse of autism's impact on older siblings 2Health News:A possible early glimpse of autism's impact on older siblings 3Health News:LazyTown Sportacus and Michelle Obama moves Washington DC 2Health News:LazyTown Sportacus and Michelle Obama moves Washington DC 3Health News:MMG Welcomes Ann Kottcamp to Leadership Team 2Health News:MMG Welcomes Ann Kottcamp to Leadership Team 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: